Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: keithcray who wrote (1464)	6/26/2001 11:37:54 AM
From: Jeff Jordan	Respond to of 208838

Like clockwork the market breaks down...

To: keithcray who wrote (1464)	6/26/2001 11:43:06 AM
From: SusieQ1065	Respond to of 208838

11:39 ET eBay (EBAY) 68.51 -2.53 (-3.5%): -- Technical -- Trading pace picks up as stock pushes to a new session low. Intraday indicators are weakening and dailies potentially topping out. Short term takes rebound back through 69.50/69.80 to neutralize. Next support on failure is at 68/67.50 with more important floor at 66.50/66.30 (May/June range top).

To: keithcray who wrote (1464)	6/26/2001 11:46:07 AM
From: westpacific	Read Replies (1) \| Respond to of 208838

Watch RCOM short in relation to VRSN. Top is 13.50 so stop just above that for squeeze.

To: keithcray who wrote (1464)	6/26/2001 11:50:15 AM
From: SusieQ1065	Respond to of 208838

10:36 ET Genzyme (GENZ) 54.18 +1.66 (+3.2%): Hearing from Merrill Lynch that firm raising estimates after GENZ announced preliminary results of a clinical study using Renagel to prevent coronary calcification and cardiac events. Firm thinks the data were impressive; raising Renagel sales estimates to reflect strong results: '01 to $150 mln from $140 mln; '02 to $250 mln from $205 mln; '03 to $357 mln from $293 mln; '04 to $500 mln from $410 mln. Increases 5-yr growth rate to 22% from 20%.